Characterization of the human Glvr-1 phosphate transporter/retrovirus receptor gene and promoter region.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 9889306)

Published in Gene on January 08, 1999

Authors

G Palmer1, D Manen, J P Bonjour, J Caverzasio

Author Affiliations

1: Division of Bone Diseases, WHO Collaborating Center for Osteoporosis and Bone Diseases, Department of Internal Medicine, University Hospital, Geneva, Switzerland.

Articles by these authors

Dietary supplementation in elderly patients with fractured neck of the femur. Lancet (1990) 4.47

Vitamin-D-receptor-gene polymorphisms and change in lumbar-spine bone mineral density. Lancet (1995) 3.82

Protein supplements increase serum insulin-like growth factor-I levels and attenuate proximal femur bone loss in patients with recent hip fracture. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1998) 2.81

Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int (1999) 2.70

Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects. J Clin Endocrinol Metab (1992) 2.42

Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation. J Bone Miner Res (2003) 1.82

Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency. J Clin Invest (1997) 1.81

Pregnancy-associated osteoporosis. Lancet (1996) 1.51

Osteoporosis, genetics and hormones. J Mol Endocrinol (2001) 1.49

Bone response to intermittent parathyroid hormone is altered in mice null for {beta}-Arrestin2. Endocrinology (2005) 1.49

Survival and potential years of life lost after hip fracture in men and age-matched women. Osteoporos Int (2002) 1.47

Familial resemblance for bone mineral mass is expressed before puberty. J Clin Endocrinol Metab (1998) 1.39

Stimulation of ADH release by the renin-angiotensin system. Am J Physiol (1970) 1.39

Inorganic phosphate homeostasis. Renal adaptation to the dietary intake in intact and thyroparathyroidectomized rats. J Clin Invest (1976) 1.29

A prospective study on socioeconomic aspects of fracture of the proximal femur. J Bone Miner Res (1996) 1.27

Phosphate is a specific signal for ATDC5 chondrocyte maturation and apoptosis-associated mineralization: possible implication of apoptosis in the regulation of endochondral ossification. J Bone Miner Res (2003) 1.19

Evidence for a role of p38 MAP kinase in expression of alkaline phosphatase during osteoblastic cell differentiation. Bone (2002) 1.18

Impaired biotin status in anticonvulsant therapy. Ann Neurol (1982) 1.17

Effects of calcium supplements on femoral bone mineral density and vertebral fracture rate in vitamin-D-replete elderly patients. Osteoporos Int (1994) 1.15

Preferential low bone mineral density of the femoral neck in patients with a recent fracture of the proximal femur. Osteoporos Int (1991) 1.14

Sodium-dependent phosphate transport inhibited by parathyroid hormone and cyclic AMP stimulation in an opossum kidney cell line. J Biol Chem (1986) 1.10

Benefits of oral protein supplementation in elderly patients with fracture of the proximal femur. J Am Coll Nutr (1992) 1.09

Renal extraction of PAH, GFR, and UNaV in the rat during infusion of angiotensin. Am J Physiol (1969) 1.08

Vitamins and alcoholism. V. Riboflavin, VI. Niacin, VII. Pantothenic acid, and VIII. Biotin. Int J Vitam Nutr Res (1980) 1.08

Change of tubular reabsorption of sodium and water after renal denervation in the dog. J Physiol (1969) 1.07

Asynchrony between the rates of standing height gain and bone mass accumulation during puberty. Osteoporos Int (1997) 1.06

Plasma concentrations of ADH in conscious and anesthetized dogs. Am J Physiol (1970) 1.06

The influence of pubertal timing on bone mass acquisition: a predetermined trajectory detectable five years before menarche. J Clin Endocrinol Metab (2009) 1.06

Evidences for a role of p38 MAP kinase in the stimulation of alkaline phosphatase and matrix mineralization induced by parathyroid hormone in osteoblastic cells. Bone (2007) 1.05

Regulation of the metabolism of 25-hydroxyvitamin D3 in primary cultures of chick kidney cells. J Clin Invest (1979) 1.04

Vitamin D supplementation during infancy is associated with higher bone mineral mass in prepubertal girls. J Clin Endocrinol Metab (1999) 1.04

Genetic aspects of osteoporosis. Curr Opin Rheumatol (1999) 1.04

Central action of angiotensin in stimulating ADH release. Am J Physiol (1971) 1.03

Do dietary calcium and age explain the controversy surrounding the relationship between bone mineral density and vitamin D receptor gene polymorphisms? J Bone Miner Res (1998) 1.03

Vitamin status in patients on chronic anticonvulsant therapy. Int J Vitam Nutr Res (1982) 1.03

Relation between alkaline phosphatase and Ca 2+ -ATPase in calcium transport. Nat New Biol (1972) 1.02

Vitamin D receptor gene start codon polymorphisms (FokI) and bone mineral density: interaction with age, dietary calcium, and 3'-end region polymorphisms. J Bone Miner Res (1998) 1.02

Role of N-cadherin and protein kinase C in osteoblast gene activation induced by the S252W fibroblast growth factor receptor 2 mutation in Apert craniosynostosis. J Bone Miner Res (2001) 1.01

Protein undernutrition-induced bone loss is associated with decreased IGF-I levels and estrogen deficiency. J Bone Miner Res (2000) 1.01

Insulin-induced stimulation of Na+,K(+)-ATPase activity in kidney proximal tubule cells depends on phosphorylation of the alpha-subunit at Tyr-10. Mol Biol Cell (1999) 1.01

Sequential and precise in vivo measurement of bone mineral density in rats using dual-energy x-ray absorptiometry. J Bone Miner Res (1992) 1.00

Fibroblast growth factor-2 (FGF-2) increases N-cadherin expression through protein kinase C and Src-kinase pathways in human calvaria osteoblasts. J Cell Biochem (2001) 1.00

Longitudinal measurement of regional and whole body bone mass in young healthy adults. Osteoporos Int (1994) 0.99

Excretion of organic acids associated with biotin deficiency in chronic anticonvulsant therapy. Int J Vitam Nutr Res (1984) 0.98

Action of 1,25-dihydroxyvitamin D3 and a diphosphonate on calcium metabolism in rats. Am J Physiol (1975) 0.98

Expression of a newly identified phosphate transporter/retrovirus receptor in human SaOS-2 osteoblast-like cells and its regulation by insulin-like growth factor I. Endocrinology (1997) 0.98

Editorial: Diphosphonate treatment in bone disease. N Engl J Med (1973) 0.98

Inhibition of renin secretion by vasopressin in unanesthetized sodium-deprived dogs. Am J Physiol (1971) 0.98

Rapid differential diagnosis of carboxylase deficiencies and evaluation for biotin-responsiveness in a single blood sample. Clin Chim Acta (1985) 0.97

Osteoporosis as a pediatric problem. Pediatr Clin North Am (1995) 0.97

Calcium-dependent, parathyroid hormone-independent regulation of 1,25-dihydroxyvitamin D. Am J Physiol (1980) 0.96

Prerequisites for the natriuretic effect of val-5-angiotensin II amide in the rat. Am J Physiol (1968) 0.96

Relationship between bone mineral density and dietary intakes in the elderly. Osteoporos Int (1993) 0.96

Autocrine stimulation of osteoblast activity by Wnt5a in response to TNF-α in human mesenchymal stem cells. Biochem Biophys Res Commun (2012) 0.96

Biotin status of epileptics. Ann N Y Acad Sci (1985) 0.95

Bone mineral mass and calcium and phosphate metabolism in young men: relationships with vitamin D receptor allelic polymorphisms. J Clin Endocrinol Metab (1999) 0.95

Osteoporosis in patients undergoing lung transplantation. Eur Respir J (1996) 0.95

Recovery of proximal tibia bone mineral density and strength, but not cancellous bone architecture, after long-term bisphosphonate or selective estrogen receptor modulator therapy in aged rats. Bone (2002) 0.95

Transforming growth factor-beta stimulates inorganic phosphate transport and expression of the type III phosphate transporter Glvr-1 in chondrogenic ATDC5 cells. Endocrinology (2000) 0.94

A copy-number mutant of plasmid pSC101. Mol Microbiol (1991) 0.94

Determinants of peak bone mass and mechanisms of bone loss. Osteoporos Int (1999) 0.94

Bone mineral density in patients with end-stage renal failure. Am J Nephrol (1993) 0.94

Regulation of alkaline phosphatase activity by p38 MAP kinase in response to activation of Gi protein-coupled receptors by epinephrine in osteoblast-like cells. Endocrinology (1999) 0.94

Arginine increases insulin-like growth factor-I production and collagen synthesis in osteoblast-like cells. Bone (1998) 0.93

Oligo-amenorrheic long-distance runners may lose more bone in spine than in femur. Med Sci Sports Exerc (2001) 0.93

Assessment of whole-body composition with dual-energy x-ray absorptiometry. Radiology (1992) 0.93

Regulation of parathyroid hormone-related protein production in a human lung squamous cell carcinoma line. J Endocrinol (1994) 0.93

Effect of 1,25-dihydroxyvitamin D3 on the renal handling of Pi in thyroparathyroidectomized rats. J Clin Invest (1977) 0.92

Role of 1,25-dihydroxyvitamin D3 on intestinal phosphate absorption in rats with a normal vitamin D supply. J Clin Invest (1977) 0.91

Renal secretion of diphosphonates in rats. Kidney Int (1975) 0.91

In vivo expression of transcripts encoding the Glvr-1 phosphate transporter/retrovirus receptor during bone development. Bone (1999) 0.91

Biotin in man's nutrition and therapy -- a review. Int J Vitam Nutr Res (1977) 0.91

Adaptation of phosphate transport in phosphate-deprived LLC-PK1 cells. Am J Physiol (1985) 0.90

Inhibition of vitamin D metabolism by ethane-1-hydroxyl-1, 1-diphosphonate. Arch Biochem Biophys (1974) 0.90

Catecholamines stimulate the proliferation and alkaline phosphatase activity of MC3T3-E1 osteoblast-like cells. Bone (1998) 0.90

Fluoride: mode of action. Bone (1998) 0.89

Relation between bone mineralization, Ca absorption, and plasma Ca in phosphonate-treated rats. Am J Physiol (1977) 0.89

Measurement of glomerular filtration rate in conscious unrestrained rats with inulin infused by implanted osmotic pumps. Am J Physiol (1985) 0.89

The vitamin d receptor gene and calcium metabolism. Trends Endocrinol Metab (1998) 0.89

Parathyroid hormone-related protein production by primary cultures of mammary epithelial cells. J Cell Physiol (1992) 0.89

Bone density and shape as determinants of bone strength in IGF-I and/or pamidronate-treated ovariectomized rats. Osteoporos Int (1996) 0.88

The influence of a diphosphonate on the intestinal absorption of calcium. Isr J Med Sci (1971) 0.88

A thymoma as a cause of true ectopic hyperparathyroidism. J Clin Endocrinol Metab (1994) 0.88

Fractures during childhood and adolescence in healthy boys: relation with bone mass, microstructure, and strength. J Clin Endocrinol Metab (2011) 0.87

Interleukin-1 decreases renal sodium reabsorption: possible mechanism of endotoxin-induced natriuresis. Am J Physiol (1987) 0.87

A novel in vitro culture system for analysis of functional role of phosphate transport in endochondral ossification. Bone (2000) 0.87

In vivo and in vitro studies of a copy number mutation of the RepA replication protein of plasmid pSC101. J Bacteriol (1993) 0.87

Evidence for the involvement of two pathways in activation of extracellular signal-regulated kinase (Erk) and cell proliferation by Gi and Gq protein-coupled receptors in osteoblast-like cells. J Bone Miner Res (2000) 0.87